PASSKEY
Live / Applied — Second extension granted (statement of use) (as of 25 Sept 2025)
What this means for you
Not registered yet, but its 05 Oct 2023 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 98211025
- Mark type
- Stylized text
- Filed
- 05 Oct 2023
- Published for opposition
- 06 Aug 2024
- Attorney of record
- Joyce Liou
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceuticals for the treatment of cancer, immunological diseases, metabolic diseases, and neurodegenerative diseases
Owner
- Passkey Therapeutics, Inc., Cambridge, MA, US
- Passkey Therapeutics, Inc., Cambridge, MA, US
Prosecution history
- 16 Jan 2026 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 16 Jan 2026 — APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
- 16 Jan 2026 — TEAS CHANGE OF OWNER ADDRESS RECEIVED
- 25 Sept 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 25 Sept 2025 — SOU EXTENSION 2 GRANTED
- 23 Sept 2025 — SOU EXTENSION 2 FILED
- 24 Sept 2025 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 23 Sept 2025 — SOU TEAS EXTENSION RECEIVED
- 22 Sept 2025 — CORRECTED NOA E-MAILED
- 22 Sept 2025 — DIVISIONAL PROCESSING COMPLETE
- 12 Mar 2025 — DIVISIONAL REQUEST RECEIVED
- 10 Jun 2025 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 12 Mar 2025 — TEAS REQUEST TO DIVIDE RECEIVED
- 07 Feb 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 07 Feb 2025 — SOU EXTENSION 1 GRANTED